Cargando…
The impact of premorbid and current intellect in schizophrenia: cognitive, symptom, and functional outcomes
BACKGROUND: Cognitive heterogeneity among people with schizophrenia has been defined on the basis of premorbid and current intelligence quotient (IQ) estimates. In a relatively large, community cohort, we aimed to independently replicate and extend cognitive subtyping work by determining the extent...
Autores principales: | Wells, Ruth, Swaminathan, Vaidy, Sundram, Suresh, Weinberg, Danielle, Bruggemann, Jason, Jacomb, Isabella, Cropley, Vanessa, Lenroot, Rhoshel, Pereira, Avril M, Zalesky, Andrew, Bousman, Chad, Pantelis, Christos, Weickert, Cynthia Shannon, Weickert, Thomas W |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4849463/ https://www.ncbi.nlm.nih.gov/pubmed/27336046 http://dx.doi.org/10.1038/npjschz.2015.43 |
Ejemplares similares
-
Genetic variation in glutamatergic genes moderates the effects of childhood adversity on brain volume and IQ in treatment-resistant schizophrenia
por: Mohamed Saini, Suriati, et al.
Publicado: (2023) -
M62. PERIPHERAL INFLAMMATION MARKERS IDENTIFY SUBSET OF PATIENTS WITH SCHIZOPHRENIA AND RELATED PSYCHOSES WHO HAVE INTELLECTUAL DECLINE FROM PREMORBID LEVELS
por: Weickert, Thomas, et al.
Publicado: (2020) -
C-Reactive Protein: Higher During Acute Psychotic Episodes and Related to Cortical Thickness in Schizophrenia and Healthy Controls
por: Jacomb, Isabella, et al.
Publicado: (2018) -
Peripheral Transcription of NRG-ErbB Pathway Genes Are Upregulated in Treatment-Resistant Schizophrenia
por: Mostaid, Md Shaki, et al.
Publicado: (2017) -
Elevated peripheral expression of neuregulin-1 (NRG1) mRNA isoforms in clozapine-treated schizophrenia patients
por: Mostaid, Md Shaki, et al.
Publicado: (2017)